Smokey, Biosect is a genius; I am here because of posters like Biosect, ATL, Doc Logic, Crash, hoffman, pqr, flipper, horseb4cart and so on. These HyCrows are simply crowing the post hoc this and that same dame thing over and over while the FDA is releasing guidance saying 'post hoc' is ok and 'adaptive trial' is ok. And biosect is saying the 'combo immunotherapy' is coming in the form of cell therapies like DcVaxL and we all know DcVaxL can't be beaten down at any time into the future as the lysate science brings the best vaccine therapy possible. Look REGN is saying what biosect is saying. We know who is behind REGN? Kevin Duffy. See the reference list put together that carefully avoids our JAMA paper. But no matter what REGN is attempting to put into their cocktail, DcVaxL is indispensable for the combo concept to work best; I bet Kevin knows that.
Market Data 
Markets 
AI
